OBJECTIVE: The aim of this study was to characterize key clinical manifestations of lysosomal acid lipase deficiency (LAL D) in children and adults. METHODS: Investigators reviewed medical records of LAL D patients ages ≥5 years, extracted historical data, and obtained prospective laboratory and imaging data on living patients to develop a longitudinal dataset. RESULTS: A total of 49 patients were enrolled; 48 had confirmed LAL D. Mean age at first disease-related abnormality was 9.0 years (range 0-42); mean age at diagnosis was 15.2 years (range 1-46). Twenty-nine (60%) were male patients, and 27 (56%) were <20 years of age at the time of consent/assent. Serum transaminases were elevated in most patients with 458 of 499 (92%) of alanine aminotransferase values and 265 of 448 (59%) of aspartate aminotransferase values above the upper limit of normal. Most patients had elevated low-density lipoprotein (64% patients) and total cholesterol (63%) at baseline despite most being on lipid-lowering therapies, and 44% had high-density lipoprotein levels below the lower limit of normal. More than half of the patients with liver biopsies (n = 31, mean age 13 years) had documented evidence of steatosis (87%) and/or fibrosis (52%). Imaging assessments revealed that the median liver volume was ∼1.15 multiples of normal (MN) and median spleen volume was ∼2.2 MN. Six (13%) patients had undergone a liver transplant (ages 9-43.5 years). CONCLUSION: This study provides the largest longitudinal case review of patients with LAL D and confirms that LAL D is predominantly a pediatric disease causing early and progressive hepatic dysfunction associated with dyslipidemia that often leads to liver failure and transplantation.

*Division of Genetics Birth Defects and Metabolism Ann and Robert H Lurie Children's Hospital of Chicago Chicago IL †Department of Medicine Addenbrooke's Hospital NHS Trust Cambridge UK ‡Medical Genetics Division Stanford University Stanford CA §Department of Pediatrics Regina Margherita Hospital Turin Italy ||Seattle Children's Hospital Seattle WA ¶Department of Vascular Medicine Internal Medicine Academic Medical Center Amsterdam The Netherlands New York Presbyterian Columbia University Medical Center New York NY **Department of Pediatrics 1st Faculty of Medicine Charles University Prague Czech Republic ††Departement de l'Enfant et de l'Adolescent Hopitaux Universitaires de Geneve Geneva Switzerland ‡‡Division of Clinical and Metabolic Genetics Hospital for Sick Children Toronto Ontario Canada §§Department of Pediatrics Unit of Rare Diseases Gaslini Institute Genoa Genova Italy ||||Department of Inherited Metabolic Disorders Birmingham Children's Hospital Birmingham UK ¶¶Department of Adult Inherited Metabolic Diseases Salford Royal NHS Foundation Salford UK Screening Department Institute of Mother and Child Warsaw Poland ***University of Minnesota Minneapolis MN †††Synageva BioPharma Corp Lexington MA ‡‡‡Hopital Necker Enfants Malades Paris France

J Pediatr Gastroenterol Nutr. 2016 Sep;63(3):e39-40. doi: 10.1097/MPG.0000000000001212. PubMed

J Pediatr Gastroenterol Nutr. 2016 Sep;63(3):e39. doi: 10.1097/MPG.0000000000001255. PubMed

See more in PubMed

Grabowski GA, Du H. Lysosomal acid lipase deficiencies: the Wolman disease/cholesteryl ester storage disease spectrum. In: Valle D, Beaudet AL, Vogelstein B, et al. eds. The Online Metabolic and Molecular Basis of Inherited Metabolic Disease. New York: McGraw-Hill; 2013.

Bernstein DL, Hülkova H, Bialer MG, et al. Cholesteryl ester storage disease: review of the findings in 135 reported patients with an underdiagnosed disease. J Hepatol 2013; 58:1230–1243. PubMed

Marshall WC, Ockenden BG, Fosbrooke AS, et al. Wolman's disease. A rare lipidosis with adrenal calcification. Arch Dis Child 1969; 44:331–341. PubMed PMC

Konno T, Fujii M, Watanuki T, et al. Wolman's disease: the first case in Japan. Tohoku J Exp Med 1966; 90:375–389. PubMed

Krivit W, Freese D, Chan KW, et al. Wolman's disease: a review of treatment with bone marrow transplantation and considerations for the future. Bone Marrow Transplant 1992; 10 suppl 1:97–101. PubMed

Jones SA, Bernstein D, Bialer M, et al. Severe and rapid disease course in the natural history of infants with lysosomal acid lipase deficiency. Mol Genet Metab 2014; 111:S57–S58.

Beaudet A, Ferry GD, Nichols BL, et al. Cholesterol ester storage disease: clinical, biochemical, and pathological studies. J Pediatr 1977; 90:910–914. PubMed

Gasche C, Aslanidis C, Kain R, et al. A novel variant of lysosomal acid lipase in cholesteryl ester storage disease associated with mild phenotype and improvement on lovastatin. J Hepatol 1997; 27:744–750. PubMed

Muntoni S, Wiebusch H, Jansen-Rust M, et al. Prevalence of cholesteryl ester storage disease. Arterioscler Thromb Vasc Biol 2007; 27:1866–1868. PubMed

Scott SA, Liu B, Nazarenko I, et al. Frequency of the cholesteryl ester storage disease common LIPA E8SJM mutation (c.894G>A) in various racial and ethnic groups. Hepatology 2013; 58:958–965. PubMed PMC

Stitziel NO, Fouchier SW, Sjouke B, et al. Exome sequencing and directed clinical phenotyping diagnose cholesterol ester storage disease presenting as autosomal recessive hypercholesterolemia. Arterioscler Thromb Vasc Biol 2013; 33:2909–2914. PubMed PMC

Zarrilli F, Elce A, Scorza M, et al. An update on laboratory diagnosis of liver inherited diseases. Biomed Res Int 2013; 2013:697940. PubMed PMC

Feldstein AE, Charatcharoenwitthaya P, Treeprasertsuk S, et al. The natural history of non-alcoholic fatty liver disease in children: a follow-up study for up to 20 years. Gut 2009; 58:1538–1544. PubMed PMC

US Census Bureau. Statistical abstract of the United States: 2012. http://www.census.gov/prod/2011pubs/12statab/pop.pdf Accessed October 6, 2014.

Alkhouri N, Sedki E, Alisi A, et al. Combined paediatric NAFLD fibrosis index and transient elastography to predict clinically significant fibrosis in children with fatty liver disease. Liver Int 2013; 33:79–85. PubMed

Angulo P, Keach JC, Batts KP, et al. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology 1999; 30:1356–1362. PubMed

Goodman ZD, Makhlouf HR, Liu L, et al. Pathology of chronic hepatitis C in children: liver biopsy findings in the Peds-C Trial. Hepatology 2008; 47:836–843. PubMed PMC

Bataller R, Brenner DA. Liver fibrosis. J Clin Invest 2005; 115:209–218. PubMed PMC

Reeder SB, Cruite I, Hamilton G, et al. Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopy. J Magn Reson Imaging 2011; 34:729–749. PubMed PMC

2014; Valayannopoulos V, Malinova V, Honzík T, et al. Sebelipase alfa over 52 weeks reduces serum transaminases, liver volume and improves serum lipids in patients with. 61:1135–1142. PubMed PMC

Thelwall PE, Smith FE, Leavitt MC, et al. Hepatic cholesteryl ester accumulation in lysosomal acid lipase deficiency: non-invasive identification and treatment monitoring by magnetic resonance. J Hepatol 2013; 59:543–549. PubMed PMC

Elleder M, Chlumska A, Hyanek J, et al. Subclinical course of cholesteryl ester storage disease in an adult with hypercholesterolemia, accelerated atherosclerosis, and liver cancer. J Hepatol 2000; 32:528–534. PubMed

Ambler GK, Hoare M, Brais R, et al. Orthotopic liver transplantation in an adult with cholesterol ester storage disease. JIMD Rep 2013; 8:41–46. PubMed PMC

Ouimet M, Marcel YL. Regulation of lipid droplet cholesterol efflux from macrophage foam cells. Arterioscler Thromb Vasc Biol 2012; 32:575–581. PubMed

Horton JD, Cohen JC, Hobbs HH. PCSK9: a convertase that coordinates LDL catabolism. J Lipid Res 2009; 50 suppl:S172–S177. PubMed PMC

Cholesterol Treatment Trialists’ Collaborators, Mihaylova B, Emberson J et al. The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials. Lancet 2012; 380:581–90. PubMed PMC

Patton HM, Yates K, Unalp-Arida A, et al. Association between metabolic syndrome and liver histology among children with nonalcoholic fatty liver disease. Am J Gastroenterol 2010; 105:2093–2102. PubMed PMC

Sanyal AJ, Chalasani N, Kowdley KV, et al. Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. N Engl J Med 2010; 362:1675–1685. PubMed PMC

Sebelipase alfa for lysosomal acid lipase deficiency: 5-year treatment experience from a phase 2 open-label extension study

See more in PubMed

ClinicalTrials.gov
NCT01528917